DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
James S. et al.
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
Am Heart J 2009;
157: 599-605.
We do not assume any responsibility for the contents of the web pages of other providers.